Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC
Abroad (travel likely)Recruiting
Conditions
Pancreatic Ductal Adenocarcinoma (PDAC) · Locally Advanced · Unresectable
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy
Guy's & St Thomas' and Kings College Hospitals, London, United Kingdom